Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease. The company is advancing a robust pipeline to precisely eliminate the root cause of multiple autoimmune and allergic conditions that are inadequately treated today. Its lead program is designed to specifically and rapidly clear the pathogenic autoantibodies that cause Graves' disease, an autoimmune disorder that affects the thyroid gland. Merida was publicly launched in April 2025 and is based in Cambridge, MA. For more information about Merida, visit www.meridabio.com.
Total raised: $121M
Investors 1
| Date | Name | Website |
| 22.05.2025 | Bain Capit... | baincapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.04.2025 | Series A | $121M | - |
Mentions in press and media 5
| Date | Title | Description |
| 16.04.2025 | The Shifting Sands of Energy: BP's Future in a Turbulent Market | The energy landscape is changing. BP, a titan in the oil industry, finds itself at a crossroads. The company is grappling with an identity crisis, and whispers of potential mergers swirl like autumn leaves in the wind. As BP prepares for it... |
| 11.04.2025 | The Week’s Biggest Funding Rounds: Base Power Fuels Somewhat Quiet Week Methodology | 2 Shares Email Facebook Twitter LinkedIn Want to keep track of the largest startup funding deals in 2025 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board. This is a w... |
| 09.04.2025 | Merida Biosciences Raises $121M in Series A Funding | Merida Biosciences, a Cambridge, MA-based biotechnology company developing a new class of precision therapeutics, raised $121M in Series A financing. The round was led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures, joi... |
| 08.04.2025 | Third Rock-backed Merida launches with $121M series A to fund autoimmune pipeline | The latest biotech to roll out of Third Rock Ventures is working on Fc-based therapeutics it hopes could offer new treatment options to patients with autoimmune disorders like Graves' disease. Merida Therapeutics was seeded by Third Rock ba... |
| - | Merida Biosciences | “Home - Merida Biosciences” |